Lam Research Corporation $LRCX Shares Sold by Artemis Investment Management LLP

Artemis Investment Management LLP reduced its position in Lam Research Corporation (NASDAQ:LRCX) by 54.1% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 296,062 shares of the semiconductor company’s stock after selling 348,799 shares during the quarter. Artemis Investment Management LLP’s holdings in Lam Research were worth $97,259,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Bayban acquired a new stake in Lam Research during the 4th quarter valued at $26,000. Vermillion Wealth Management Inc. acquired a new stake in shares of Lam Research in the first quarter worth $26,000. Cedar Mountain Advisors LLC grew its holdings in shares of Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 85 shares in the last quarter. Paladin Partners LLC purchased a new position in shares of Lam Research during the second quarter valued at $26,000. Finally, University of Illinois Foundation acquired a new position in Lam Research during the fourth quarter valued at $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on LRCX shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $320.00 price objective on shares of Lam Research in a research note on Thursday, July 30th. Stifel Nicolaus upped their target price on Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a report on Friday, July 10th. B. Riley Financial raised their price target on shares of Lam Research from $350.00 to $390.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Rothschild & Co Redburn boosted their price objective on shares of Lam Research from $305.00 to $420.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $385.00 price objective (up from $367.00) on shares of Lam Research in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $364.59.

Lam Research Stock Down 3.0%

Shares of NASDAQ LRCX traded down $9.99 during trading hours on Thursday, hitting $319.52. The stock had a trading volume of 3,292,500 shares, compared to its average volume of 10,695,956. The firm’s 50-day moving average price is $310.02 and its two-hundred day moving average price is $305.12. Lam Research Corporation has a 52 week low of $131.02 and a 52 week high of $438.50. The company has a market capitalization of $399.86 billion, a P/E ratio of 55.32, a P/E/G ratio of 1.32 and a beta of 1.85. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.13. The firm had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company’s revenue for the quarter was up 30.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Analysts anticipate that Lam Research Corporation will post 9.34 EPS for the current fiscal year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. This is a boost from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s dividend payout ratio (DPR) is presently 22.92%.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research is benefiting from continued investment in AI chips, advanced packaging and high-bandwidth memory (HBM), which is increasing demand for the company’s wafer-fabrication equipment. The stock is reportedly up about 73% this year and ranks highly among stocks with strong return on equity. Is Lam Research a Smart AI Stock Pick for Long-Term Investors?
• Positive Sentiment: Recent analysis continues to highlight Lam’s earnings growth, improving margins and consistent profitability. Its latest reported quarter exceeded consensus expectations, with revenue rising 30% year over year and EPS surpassing estimates, reinforcing the bullish fundamental case.
• Positive Sentiment: Zacks included Lam Research among chip stocks with dependable earnings that could benefit from the AI boom, alongside NVIDIA, Applied Materials and TSMC. This keeps LRCX prominent among investors seeking semiconductor exposure. 4 Top Chip Stocks With Dependable Earnings to Ride the AI Boom
• Neutral Sentiment: Lam Research is one of the most-watched stocks on Zacks, but the “trending stock” coverage reflects investor interest rather than a new company announcement or earnings catalyst. Lam Research Is a Trending Stock
• Negative Sentiment: Valuation remains the main risk. Analysts note that Lam trades at a premium to KLA relative to trailing free cash flow, so continued gains may require sustained AI-driven growth and execution. A modest premarket decline in Europe also points to some near-term caution. Lam Research vs. KLA
• Neutral Sentiment: One article references an abdominoplasty clinical trial while attributing it to Lam Research, which appears unrelated to the semiconductor-equipment company and should not be treated as relevant investment news.

Insider Buying and Selling

In related news, Director Bethany Mayer sold 9,557 shares of the company’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $314.74, for a total value of $3,007,970.18. Following the completion of the sale, the director directly owned 20,995 shares in the company, valued at approximately $6,607,966.30. This represents a 31.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Abhijit Talwalkar sold 18,282 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director directly owned 87,142 shares in the company, valued at $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 32,839 shares of company stock worth $10,644,740. Corporate insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation is a semiconductor equipment company that designs, manufactures, and services systems used in the fabrication of integrated circuits and other electronic devices. Its equipment supports key steps in the wafer manufacturing process, helping semiconductor producers create increasingly small and complex features on silicon wafers.

The company’s portfolio includes systems for etch, deposition, wafer cleaning, surface preparation, and related manufacturing processes.